We consider the possible consequences of the reduced cellular content of TFIIH for the clinical symptoms in XP-B or XP-D patients , and discuss a 'conditional phenotype' that may involve an impairment of cellular function only under certain growth conditions .
we consider the possible consequences of the reduced cellular content of tfiih for the clinical symptoms in xp-b or xp-d patients , and discuss a 'conditional phenotype' that may involve an impairment of cellular function only under certain growth conditions .
O O O O O O O O O O O B-protein_molecule O O O O O O O O O O O O O O O O O O O O O O O O O O B-other_name I-other_name O